Survival of patients with MYC family-driven neuroblastomas where the tumors had MYCN protein (+) and/or MYC protein (+) was significantly worse than that of patients with non-MYC family-driven neuroblastomas where both proteins were (−)/(+/−). This evidence concerns the gene MYCN and neuroblastoma.